Stuart Wong is Center Director, Professor at Medical College of Wisconsin. OpenAlex indexes 187 publications with 8,767 citations (h-index 35); ClinicalTrials.gov lists 15 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 24 Oct 2026
Stuart Wong, MD, is Center Director, Professor at Medical College of Wisconsin. The public record shows 187 publications with 8,767 citations (h-index 35), centered on Head and Neck Cancer Studies, Head and Neck Surgical Oncology, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 1 companies, 4 NIH-funded awards (2000–2026).
- Most recent indexed publication: 2026 · Head & neck
- Top research focus: Head and Neck Cancer Studies
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 69.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
Sponsor: National Cancer Institute (NCI)
- Antitumor-B KAC PK Study
Sponsor: Medical College of Wisconsin
Industry payments
Updated 24 Oct 2026
1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme CorporationProgram year20213 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.4%Serotonin-3 Receptor Antagonist37.4%Ondansetron Hcl100%Part D≥36 patientsCancer & immunology
30.4%Kinase inhibitor30.4%Tafinlar34%Mekinist34%Gilotrif31%Part D<11 patientsSensory organs
16.5%Corticosteroid16.5%Dexamethasone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 24 Oct 2026
4 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- Medical College of Wisconsin Lead Academic Participating Site Renewal
Medical College of Wisconsin
FY2026$651,764UG1CA233198 - MCW NCTN Lead Academic Participating Site Administrative Supplement
Medical College of Wisconsin
FY2025$569,544UG1CA233198
Congress activity
Updated 24 Oct 2026
62 congress contributions (2003–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 24 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Notably Off Key: Questioning the Clinical Benefit of Perioperative Immunotherapy for Resectable Head and Neck Squamous Cell Carcinoma After KEYNOTE-689.
Journal of clinical oncology
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
headandneck.org/team/stuart-wong-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →headandneck.org ↗ - Other
mcw.edu/departments/center-for-immunology/doctors/wong-stuart-j-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcw.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD (Doctor of Medicine)
Medical College of Wisconsin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcw.edu ↗
Editorial & leadership roles
journal and society appointments- Member
American Society of Clinical Oncology
- Member
National Cancer Institute Head and Neck Steering Committee
- Member
Eastern Cooperative Oncology Group
- Co-Chair
Head and Neck Committee, NRG Oncology
- Editorial Board
Journal of Clinical Oncology
Secondary affiliations
appointments beyond the home institution- Professor of Medicine and Otolaryngology
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Brett Kissela, MD
Medical College of Wisconsin
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Reza Shaker, MD
Medical College of Wisconsin
Neal Futran, MD
University of Washington (UW Medicine)
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Antonio Jimeno, MD
University of Colorado Cancer Center